Product Description
The global insertable cardiac monitor market was valued at over $1.32 billion in 2025. This is expected to increase over the forecast period at a CAGR of 4.6% to reach nearly $1.81 billion.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Insertable Cardiac Monitor Market Trends

The introduction of AI within insertable cardiac monitors, such as Medtronic’s AccuRhythm™ and Abbott’s ASSERT-IQ™, has shown to significantly reduce false positive alerts while still showing reliable results for clinically significant events. This is the largest driver of the insertable cardiac monitor market and supports a healthy growth forecast globally.
Global Insertable Cardiac Monitor Market Share Insights

- Medtronic remained the leading global supplier in the implantable cardiac monitor market in 2025 through its ICM portfolio, most notably the LINQ II™ and Reveal LINQ™ The LINQ II™ platform advanced Medtronic’s position through improved artificial-intelligence-driven arrhythmia detection and expanded remote monitoring capabilities, while the Reveal LINQ™ continued to serve as a widely adopted minimally invasive solution for long-term rhythm surveillance in patients with infrequent arrhythmic symptoms.
- Abbott preserved a strong second-leading position in the insertable cardiac monitor market with a portfolio that included the Confirm Rx™, Jot Dx™ and the more recent Assert-IQ™ ICM. These devices continue to support clinicians across a broad range of long-term rhythm monitoring needs by offering mobile-enabled data transmission, streamlined remote management and reliable detection of clinically significant arrhythmias.
- Boston Scientific maintained the third-leading position in the implantable cardiac monitor market through its LUX-Dx™ ICM offering in 2025. The LUX-Dx™ continues to provide long-term cardiac rhythm monitoring functionality and remains part of Boston Scientific’s portfolio for patients needing extended surveillance of arrhythmias.
Global Insertable Cardiac Monitor Market Segmentation Summary
- Insertable Cardiac Monitor Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.